OLN241220P70000
- 27.40
- 0.000.00%
Olin Newsroom
Olin Is Maintained at Equal-Weight by Barclays
Olin Analyst Ratings
Wells Fargo Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $40
RBC Capital Maintains Olin(OLN.US) With Buy Rating, Maintains Target Price $48
Deutsche Bank Adjusts Olin Price Target to $42 From $45, Maintains Hold Rating
Express News | Olin : Deutsche Bank Cuts Target Price to $42 From $45
Barclays Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $43
Olin Corp. Investor Day At 9:00 AM ET
Olin Boosts Stock Buyback Authorization to $2 Billion
Express News | Olin Corp - Expects $35 Million Pretax Restructuring Costs Through 2030
Express News | Olin Corp - to Permanently Close Chlorine 3 Facility in Freeport, Texas
Olin: Buyback Increase Reflects Continued Confidence in Earnings Potential >OLN
Express News | Olin Hosts 2024 Investor Day and Announces Increase in Share Repurchase Authorization to $2.0 Billion
KeyBanc Maintains Olin(OLN.US) With Buy Rating, Maintains Target Price $56
Olin Shares Dip as Chemours Plans New Chlor-alkali Plant
Is Olin (NYSE:OLN) A Risky Investment?
Barclays Maintains Olin(OLN.US) With Hold Rating, Maintains Target Price $45
Those Who Invested in Olin (NYSE:OLN) Five Years Ago Are up 177%
Olin Biotech (688319.SH): received a government subsidy of 2.24 million yuan.
Glonghui November 28丨 Olin Bioscience (688319.SH) announced that its wholly-owned subsidiary Chongqing Yuanlun Biological Technology Co., Ltd. recently received government subsidies totaling 2.24 million yuan, with 2.24 million yuan related to income and 0 yuan related to assets.
When Should You Buy Olin Corporation (NYSE:OLN)?